Prothena to Participate in Upcoming September Investor Conferences
(Thomson Reuters ONE) -
DUBLIN, Ireland, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc
(NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the
discovery, development, and commercialization of novel protein immunotherapies,
today announced that members of its senior management team will present and
participate in several upcoming investor conferences:
* Credit Suisse Antibody Day on September 7, 2016 at 12:00 PM ET in New York,
NY
* Citi's 11th Annual Biotech Conference on September 8, 2016 in Boston, MA
* Morgan Stanley Global Healthcare Conference on September 12, 2016 at 8:45 AM
ET in New York, NY
* The Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016 at
10:00 AM ET in New York, NY
A live webcast of the company presentations can be accessed under the Investors
tab in the Events and Presentations section of the Company's website
at www.prothena.com. Following the live presentations, a replay of each webcast
will be available on the Company's website for at least 90 days following the
presentation date.
About Prothena
Prothena Corporation plc is a global, late-stage clinical biotechnology company
seeking to fundamentally change the course of progressive diseases with its
clinical pipeline of novel therapeutic antibodies. Fueled by its deep scientific
understanding built over decades of research in protein misfolding and cell
adhesion - the root causes of many serious or currently untreatable amyloid and
inflammatory diseases - Prothena has advanced several drug candidates into
clinical trials while pursuing discovery of additional novel therapies. Our
pipeline of antibody-based product candidates targets a number of potential
indications including AL amyloidosis (NEOD001), Parkinson's disease and other
related synucleinopathies (PRX002) and inflammatory diseases, including
psoriasis (PRX003), and ATTR amyloidosis (PRX004). For more information, please
visit the company's web site at www.prothena.com.
For more information, please visit the company's web site at www.prothena.com.
Contacts
Investors: Tran Nguyen, CFO
650-837-8535, IR(at)prothena.com
Media: Ellen Rose
650-922-2405, ellen.rose(at)prothena.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Prothena Corporation plc via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 30.08.2016 - 22:05 Uhr
Sprache: Deutsch
News-ID 491868
Anzahl Zeichen: 2943
contact information:
Town:
DUBLIN
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 195 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prothena to Participate in Upcoming September Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
Prothena Corporation plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
